Brief: Annexon Biosciences Q2 basic EPS USD -0.47
07/08/2023 11:33
Aug 7 (Reuters) - Annexon Biosciences Q2 operating expenses USD 37.691 million. * Q2 basic EPS USD -0.47 * Q2 net income USD -35.188 million * Q2 income from operations USD -37.691 million * Q2 cash & investments USD 192.9 million
Recent news on Annexon
See all newsBrief: Annexon Reports Inducement Grants to New Employees
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Annexon, Inc. reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte